Daniela Iacono

1.6k total citations
19 papers, 372 citations indexed

About

Daniela Iacono is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Daniela Iacono has authored 19 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Daniela Iacono's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (7 papers) and HER2/EGFR in Cancer Research (4 papers). Daniela Iacono is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Research Studies (7 papers) and HER2/EGFR in Cancer Research (4 papers). Daniela Iacono collaborates with scholars based in Italy, Lebanon and United Kingdom. Daniela Iacono's co-authors include Rita Chiari, Lucio Crinò, Vincenzo Minotti, Maria Grazia Mameli, Paolo Marchetti, Antonella Flacco, Raffaele Giusti, Vienna Ludovini, Renato Colella and Francesca Romana Tofanetti and has published in prestigious journals such as Annals of Oncology, Lara D. Veeken and Journal of Thoracic Oncology.

In The Last Decade

Daniela Iacono

19 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Iacono Italy 9 266 228 141 64 34 19 372
Kentaro Ito Japan 14 473 1.8× 400 1.8× 213 1.5× 112 1.8× 33 1.0× 66 699
M Paesmans Belgium 5 196 0.7× 225 1.0× 159 1.1× 75 1.2× 22 0.6× 6 455
Christina L. Gersch United States 12 83 0.3× 263 1.2× 136 1.0× 100 1.6× 24 0.7× 30 472
Xiaoyi Hu China 10 180 0.7× 170 0.7× 144 1.0× 58 0.9× 15 0.4× 34 448
Atsushi Nagase Japan 8 228 0.9× 210 0.9× 135 1.0× 43 0.7× 27 0.8× 22 383
Sung Jin Yoon South Korea 10 733 2.8× 613 2.7× 233 1.7× 134 2.1× 33 1.0× 18 904
Xiliang Cong China 9 150 0.6× 283 1.2× 129 0.9× 112 1.8× 22 0.6× 14 479
E‐E Ke China 8 239 0.9× 200 0.9× 80 0.6× 51 0.8× 13 0.4× 12 315
Kaoru Irisa Japan 9 236 0.9× 214 0.9× 76 0.5× 48 0.8× 23 0.7× 16 333
Stéphanie Héon United States 7 395 1.5× 360 1.6× 73 0.5× 29 0.5× 9 0.3× 10 444

Countries citing papers authored by Daniela Iacono

Since Specialization
Citations

This map shows the geographic impact of Daniela Iacono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Iacono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Iacono more than expected).

Fields of papers citing papers by Daniela Iacono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Iacono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Iacono. The network helps show where Daniela Iacono may publish in the future.

Co-authorship network of co-authors of Daniela Iacono

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Iacono. A scholar is included among the top collaborators of Daniela Iacono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Iacono. Daniela Iacono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Iacono, Daniela, Maria Rita Migliorino, Lucia Grillo, et al.. (2019). Intrapatient Molecular and Histologic Heterogeneity After First-generation or Second-generation TKI Therapy of NSCLC Patients. American Journal of Clinical Oncology. 42(11). 845–850. 7 indexed citations
2.
Vitale, Maria Giuseppa, Debora Basile, Elisa Bertoli, et al.. (2019). Impact of sarcopenia in patients with metastatic melanoma treated with immunotherapy. Annals of Oncology. 30. v558–v558. 1 indexed citations
3.
Fuggetta, Maria Pia, Maria Rita Migliorino, Serena Ricciardi, et al.. (2019). Prophylactic Dermatologic Treatment of Afatinib-Induced Skin Toxicities in Patients with Metastatic Lung Cancer: A Pilot Study. Scientifica. 2019. 1–6. 8 indexed citations
4.
Filetti, Marco, Raffaele Giusti, Arianna Di Napoli, Daniela Iacono, & Paolo Marchetti. (2019). Unexpected serious aplastic anemia from PD-1 inhibitors: beyond what we know. Tumori Journal. 105(6). NP48–NP51. 5 indexed citations
5.
6.
Giusti, Raffaele, Paolo Bossi, Marco Mazzotta, et al.. (2017). The use of fentanyl in pain management in head and neck cancer patients: a narrative review. British Journal of Pain. 12(3). 155–162. 11 indexed citations
7.
Giusti, Raffaele, Marco Mazzotta, Daniela Iacono, Salvatore Di Lauro, & Paolo Marchetti. (2017). Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report. Clinical Drug Investigation. 37(6). 581–585. 1 indexed citations
8.
Onesti, Concetta Elisa, Daniela Iacono, Salvatore Di Lauro, et al.. (2016). Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature. Translational Lung Cancer Research. 5(6). 712–719. 12 indexed citations
9.
Scarpino, Stefania, Gian Luca Rampioni Vinciguerra, Arianna Di Napoli, et al.. (2016). High prevalence of ALK+/ROS1+ cases in pulmonary adenocarcinoma of adoloscents and young adults. Lung Cancer. 97. 95–98. 27 indexed citations
10.
11.
Mazzotta, Marco, Raffaele Giusti, Daniela Iacono, Salvatore Di Lauro, & Paolo Marchetti. (2016). Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma. Case Reports in Oncological Medicine. 2016. 1–5. 13 indexed citations
12.
Chiari, Rita, Giulio Metro, Daniela Iacono, et al.. (2015). Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis. Lung Cancer. 90(2). 255–260. 36 indexed citations
13.
Iacono, Daniela, Rita Chiari, Giulio Metro, et al.. (2015). Future options for ALK-positive non-small cell lung cancer. Lung Cancer. 87(3). 211–219. 50 indexed citations
14.
Chiari, Rita, Fiamma Buttitta, Daniela Iacono, et al.. (2014). Dramatic Response to Crizotinib in ROS1 Fluorescent In Situ Hybridization- and Immunohistochemistry-Positive Lung Adenocarcinoma: A Case Series. Clinical Lung Cancer. 15(6). 470–474. 12 indexed citations
15.
Giusti, Raffaele, Daniela Iacono, Ida Paris, Luigi Ruco, & Paolo Marchetti. (2012). Multidisciplinary approach to fetal adenocarcinoma of the lung: A case report. Thoracic Cancer. 5(1). 97–100. 1 indexed citations
16.
Gori, Stefania, Jennifer Foglietta, Maria Grazia Mameli, et al.. (2012). HER-3 status by immunohistochemistry in HER-2-positive metastatic breast cancer patients treated with trastuzumab: correlation with clinical outcome.. PubMed. 98(1). 39–44. 6 indexed citations
17.
Gori, Stefania, Jennifer Foglietta, Maria Grazia Mameli, et al.. (2012). HER-3 Status by Immunohistochemistry in HER-2-Positive Metastatic Breast Cancer Patients Treated with Trastuzumab: Correlation with Clinical Outcome. Tumori Journal. 98(1). 39–44. 6 indexed citations
18.
19.
Lupoli, Giovanni, et al.. (2011). Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life. Medical Science Monitor. 17(8). CR442–CR448. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kentaro Ito Breakdown of academic impact, for papers by M Paesmans Breakdown of academic impact, for papers by Christina L. Gersch Breakdown of academic impact, for papers by Xiaoyi Hu Breakdown of academic impact, for papers by Atsushi Nagase Breakdown of academic impact, for papers by Sung Jin Yoon Breakdown of academic impact, for papers by Xiliang Cong Breakdown of academic impact, for papers by E‐E Ke Breakdown of academic impact, for papers by Kaoru Irisa Breakdown of academic impact, for papers by Stéphanie Héon
Rankless by CCL
2026